Palantir Technologies lifts guidance after Q2 results beat Wall Street estimates
French Glendon E. III, a director at Pulmonx Corp (NASDAQ:LUNG), recently sold shares worth $459,085, according to a filing with the Securities and Exchange Commission. The transactions, dated February 20, 2025, involved the sale of 55,453 shares of Pulmonx’s common stock. The shares were sold at prices ranging from $7.60 to $9.11. The stock has shown remarkable strength recently, posting a 28.55% gain in the past week, with InvestingPro data indicating the stock is currently in overbought territory.
The sales were conducted under a Rule 10b5-1 trading plan, which allows insiders to set up a predetermined plan to sell company stock. Glendon now holds 1,011,974 shares following the transactions. This activity comes as part of routine financial planning and portfolio management by the director. The company maintains strong financial health with a current ratio of 5.58 and has achieved 22% revenue growth in the last twelve months. For comprehensive insider trading analysis and additional insights, investors can access detailed reports through InvestingPro, which offers extensive coverage of over 1,400 US stocks.
In other recent news, Pulmonx Corp reported a strong performance in its fourth-quarter 2024 earnings, with revenue reaching $23.8 million, a 23% increase from the previous year. This figure surpassed the consensus estimate of $22.3 million, driven by notable international revenue growth of 42% and a 16% increase in U.S. revenue. The company reported an earnings per share (EPS) of -$0.33, which was better than the forecasted -$0.4475, indicating improved financial management. Citi analysts responded to these results by raising their price target for Pulmonx shares from $7.50 to $8.00, maintaining a Neutral rating. Despite this, the company experienced a slight decrease in gross margins, which fell to 74.0% from 74.7% year-over-year. Pulmonx’s management has provided guidance for 2025, projecting revenue between $96 million and $98 million, which would represent a growth of 16%-18% excluding foreign exchange impacts. The company continues to focus on expanding its market presence through new product launches and international expansion, which are expected to drive future growth.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.